Conference0Bukhara, May 12, 2017 – The U.S. Agency for International Development (USAID) supports a National Conference with International Participation in Bukhara, bringing international experts to share best practices in patient-centered care of tuberculosis (TB). The patient-centered approach to TB care is one of the pillars of the World Health Organization’s (WHO) “End TB” Strategy, which was adopted in 2014 at the 67th session of the World Health Assembly. The Strategy sets targets of a 95% reduction in TB deaths and a 90% reduction in TB cases by 2035 as compared to 2015 and aims to ensure that no family is burdened with catastrophic expenses as a result of TB.

The conference was facilitated with USAID funding along with the Republic of Uzbekistan Ministry of Health (MOH), and the Uzbekistan National Specialized Research and Practical Medical Center for Tuberculosis and Pulmonology (Center for Tuberculosis and Pulmonology). The conference in Bukhara provided a forum to effectively share knowledge, experience, expertise, successes, and lessons learned among leading Uzbekistan and international TB and public health professionals, including experts from WHO and USAID.

As part of the Bukhara Conference, on May 10, 2017, USAID and the national partners also held master classes at the Center for Tuberculosis and Pulmonology in Tashkent for healthcare professionals and laboratory specialists from across Uzbekistan. The world’s leading experts from the United States, Russia, Uzbekistan, and South Africa shared their practical expertise in infection control, TB laboratory diagnostics, and the role of nurses in patient-centered TB care.

At the conclusion, the conference participants developed recommendations for implementation of patient-centered approaches in the treatment of TB and identified priority actions for sustainable support, coordination and implementation of the End TB Strategy in Uzbekistan

USAID supports the Republic of Uzbekistan Ministry of Health in implementing the National TB Program by providing more effective and accessible TB prevention, diagnosis, and treatment for all, including vulnerable populations. The main objective of the five-year, $7.6 million USAID TB Control Program is to reduce the burden of tuberculosis and prevent multidrug-resistant forms of the disease. The program covers a wide range of technical areas, including strengthening the health system’s human and institutional capacity, improving interagency coordination and cooperation, and increasing access to TB diagnosis and treatment.


This blog is the product of an activity that has received funding under an operating grant from the European Union’s Health Programme (2014-2020).

The content of this blog represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.